Raktamarisha Ghana vati (An anubhuta yoga) in Garbhini Pandu.

An open labelled single arm clinical study of Raktamarisha Ghana vati in Garbhini Pandu.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020493

Enrollment

Registered

2019-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I998- Other disorder of circulatory system

Interventions

Intervention1: Raktamarisha Ghana vati (An anubhuta yoga): Drug:- Raktamarisha Ghana vati will be prepared by making Kwatha Kalpana from Raktamarisha,and ghana will be obtained after boiling kwatha an

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hb below 10% and above 7% 2.All Garbhini patients fulfilling diagnostic criteria of Pandu. 3.Iron deficiency anaemia, microcytic Hypochromic anaemia, microcytic Normochromic Anemia. 3.2nd and 3 rd trimester patients.

Exclusion criteria

Exclusion criteria: 1.Multiple pregnancy. 2.Bad Obstetrics history and precious pregnancy. 3.Drug allergy. 4.Haemoglobinopathies like thalassemia, sickle cell anemia, pernicious anemia etc Anemia associated with the haemorrhagic disorders. 5.High risk pregnancy. 6.Secondary anaemia.

Design outcomes

Primary

Measure	Time frame
Effect of Raktamarisha Ghana vati (An anubhuta yoga) in Garbhini Pandu. Efficiency of Raktamarisha as a Pathya in pregnancy. Healthy baby with Healthy mother.Timepoint: 2 months	—

Secondary

Measure	Time frame
Literary review of Raktamarisha will b carried out. Complications due to Anaemia will reduce. Timepoint: 2 months	—

Countries

India

Contacts

Public ContactVd Manda Sanjiv Ghorpade

Maharashtra Arogya Mandal.

mandaghorpade@yahoo.com9822007570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026